drugset / Trial / NCT03052660

Impact of Preoperative Midazolam on Outcome of Elderly Patients

NCT03052660

Phase 4 Completed 782 enrolled RWTH Aachen University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

We aim to assess, if placebo compared to preoperative administration of midazolam in elderly patients is equal in regard to the global postoperative patient satisfaction

Timeline

Start
2017-10-12
Primary completion
2019-06-24
Completion
2019-06-24

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 3.75 mg Oral

Indications

No indication recorded.